Open AccessThe use of midostaurin in aggressive systemic mastocytosis (ASM) with the c-KIT D816V mutation within The Emergency Access to Drug Technologies Programme
Author(s) -
Alan Majeranowski,
Andrzej Mital
Publication year - 2021
Language(s) - English
Resource type - Journals
ISSN - 2720-1015
DOI - 10.5603/hcp.2021.0011
Subject(s) - systemic mastocytosis , midostaurin , cladribine , medicine , imatinib , alpha interferon , dasatinib , oncology , pharmacology , leukemia , immunology , interferon , bone marrow , myeloid leukemia